Cargando…

Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS

Information is lacking concerning concomitant administration of enteric-coated mycophenolate sodium with tacrolimus (EC-MPS+Tac) in renal transplant recipients (RTxR). In this 6-month, prospective, open-label, multicenter study, de novo RTxR were randomized (1 : 1) to low-dose (LD) or standard-dose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Laurence, Andres, Amado, Bunnapradist, Suphamai, Gugliuzza, Kristene, Parasuraman, Ravi, Peddi, V. Ram, Cassuto, Elisabeth, Hart, Marquis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512323/ https://www.ncbi.nlm.nih.gov/pubmed/23227307 http://dx.doi.org/10.1155/2012/941640

Ejemplares similares

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients
por: Gaber, A. Osama, et al.
Publicado: (2013)

Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial
por: Suwelack, Barbara, et al.
Publicado: (2020)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Adenovirus in a Kidney Transplant Recipient
por: Lum, Erik L., et al.
Publicado: (2023)

Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial
por: Faravardeh, Arman, et al.
Publicado: (2021)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

Epidermal Cysts in a Tacrolimus Treated Renal Transplant Recipient
por: Ahn, In Su, et al.
Publicado: (2011)

Massive pleural effusion in a renal transplant recipient on tacrolimus
por: Nayagam, L. S., et al.
Publicado: (2014)

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
por: De Simone, P, et al.
Publicado: (2012)

Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged‐Release Tacrolimus Regimens—The DIAMOND Study
por: TruneČka, P., et al.
Publicado: (2015)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients
por: Yan, Lin, et al.
Publicado: (2019)

629. Blood Transcriptome Variations Predict Infection and Rejection in the Older Kidney Transplant Recipient
por: Schaenman, Joanna, et al.
Publicado: (2018)

Tacrolimus as a Rare Cause of Pericardial Effusion in a Renal Transplant Recipient
por: Prashar, Rohini, et al.
Publicado: (2017)

Random pharmacokinetic profiles of EC-MPS in children with autoimmune disease
por: Filler, Guido, et al.
Publicado: (2010)

Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate‐ or prolonged‐release tacrolimus
por: Vondrak, Karel, et al.
Publicado: (2019)

BK Viremia Exacerbation With Adalimumab Coadministration
por: Lum, Erik L., et al.
Publicado: (2020)

A Neutral Risk on the Development of New-Onset Diabetes Mellitus (NODM) in Taiwanese Patients with Dyslipidaemia Treated with Fibrates
por: Lee, Chien-Ying, et al.
Publicado: (2012)

New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy
por: Chaitou, Ali R, et al.
Publicado: (2022)

Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
por: Chegounchi, Marjan, et al.
Publicado: (2006)

Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients
por: Tang, Jie, et al.
Publicado: (2017)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
por: Chen, Lucy, et al.
Publicado: (2018)

Endoscopic Botulinum Toxin Injection for Tacrolimus-Induced Achalasia in a Renal Transplant Recipient
por: Campos, Marilia, et al.
Publicado: (2019)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Serial Peripheral Blood Gene Expression Profiling to Assess Immune Quiescence in Kidney Transplant Recipients with Stable Renal Function
por: Peddi, V. Ram, et al.
Publicado: (2020)

Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus
por: Kreijveld, Ellen, et al.
Publicado: (2008)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

Corrigendum: Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients
por: Tang, Jie, et al.
Publicado: (2018)

A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients
por: Tang, Jiang-Tao, et al.
Publicado: (2018)

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
por: Chapman, William C., et al.
Publicado: (2017)

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
por: Kamar, Nassim, et al.
Publicado: (2018)

Differences in Gene Expression in Older Compared With Younger Kidney Transplant Recipients
por: Schaenman, Joanna M., et al.
Publicado: (2019)

The Prevalence of Immunologic Injury in Renal Allograft Recipients with De Novo Proteinuria
por: Sun, Qiquan, et al.
Publicado: (2012)

Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome
por: Tatapudi, Vasishta S., et al.
Publicado: (2018)

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
por: Handisurya, Ammon, et al.
Publicado: (2016)

Tacrolimus Aggravated Tube Feeding Syndrome with Acute Renal Failure in a Pediatric Liver Transplant Recipient
por: Kula, R., et al.
Publicado: (2017)

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients
por: Andrews, L. M., et al.
Publicado: (2019)

Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients
por: Htun, Yi Yi, et al.
Publicado: (2020)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection
por: Bunnapradist, Suphamai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mvp3mbusd6lv1qfglc9ncr0hah